Infections associated with prosthetic joints cause significant morbidity and account for a substantial proportion of healthcare expenditure ([@CIT0003]). The management of infection associated with prosthetic joints is poorly standardized because of the varied clinical presentations and the lack of data from randomized, controlled trials. We have recently published a treatment algorithm that was developed at the Kantonsspital Liestal over the past 25 years ([@CIT0043]). Adherence to this treatment concept has shown a success rate of 85--100% in curing infection ([@CIT0011], [@CIT0034]).

Successful treatment of prosthetic hip joint infection (PI) consists not only of eliminating the infection but also of restoring patient mobility, which is important for patient satisfaction ([@CIT0004]). Even so, functional and radiographic outcome has been mainly investigated in aseptic revisions ([@CIT0033]). Ideally, the evaluation of any treatment algorithm for PI should be from a multidisciplinary perspective, including infectiological, radiographic, and functional outcome.

Our surgical technique and choice of components are entirely dictated by the quality of soft tissue and bone. In our view, the functional outcome after 1-stage exchange for PI should therefore be similar to that for aseptic reasons. After 2-stage exchange, this outcome is expected to be worse because this intervention is commonly performed in patients with more severe infections, requiring a more complex surgical procedure. Moreover, in revision hip surgery and especially in cases with PI, patient and surgical factors (e.g. femoral osteotomy and components) are highly variable because of the different quality of soft tissue and bone in individual cases. Thus, when reporting on functional outcome in cases of PI, the presence of such factors should be acknowledged and their possible influence on outcome analyzed.

Because elimination of the infection is a prerequisite for a good functional outcome, we first wanted to confirm that our treatment algorithm is associated with successful infectiological outcome as reported in previous studies ([@CIT0011], [@CIT0034]). Since these reports were published, 37 additional hips have been treated accordingly and could be included for analysis of infectiological outcome. Secondly, we wanted to determine whether functional and radiographic outcome, aseptic revision, and complication rate would be different (1) after 1-stage exchange for PI as compared to 1-stage aseptic revisions, and (2) after 1-stage exchange for PI as compared to 2-stage exchange. We hypothesized that all outcomes would be similar in 1-stage groups and lower after 2-stage exchange. Thirdly, we wanted to determine whether functional outcome was affected by various pre-defined surgery-related parameters.

Patients and methods {#ss2}
====================

Population {#ss3}
----------

We retrospectively analyzed all patients who had been treated with exchange of a THA, because of PI, at our center between 1985 and 2004. We formed 3 groups. The "1-stage exchange due to PI" group (group 1), a matched aseptic control group (Control), and the "2-stage exchange" group (group 2) who were analyzed separately. Functional and radiographic parameters, rates of revision, and complications were compared between controls and group 1, and between group 1 and group 2. A transfemoral osteotomy, a deficient greater trochanter, a 2-stage revision, a history of multiple cup or stem revision, a BS-ring, or a Wagner stem were identified to possibly lead to a lower HHS, and/or more limping or use of support. In order to analyze whether or not these variables independently influenced functional outcome all hips with an event-free follow-up were pooled in one single study group and variables were analyzed separately.

To establish the diagnosis of PI, the presence of a sinus tract or the growth of the same microorganism in at least 2 cultures, or inflammation consistent with infection on histopathological examination was required ([@CIT0011], [@CIT0042]). Hips with a PI were only included if treatment was strictly according to the algorithm and an exchange of the implant had been done ([@CIT0043]) ([Figure 1](#F1){ref-type="fig"}). Antimicrobial compounds were selected as described previously ([@CIT0043]) and typically administered for 8--12 weeks. Hips were excluded when results were not available 2 years after the index operation, or if they were lost to follow-up or when documentation was poor.

![The algorithm showing decision making for a 1-stage or 2-stage revision.](ORT-0300-9734-082-027_g001){#F1}

91 hips were treated with a 1-stage exchange or a 2-stage exchange because of PI. 12 hips were considered not to have been treated according to the algorithm and were excluded: in 2 hips the infection was detected after death, in 2 hips treatment of infection was declined, in 4 hips components remained in site despite the presence of severe soft tissue damage because the operation risk due to co-morbidities was inordinately high and in 4 hips the infection was unknown during revision and therefore treatment started too late. In group 1, 1 hip was excluded due to loss of 2 year follow-up and another hip because follow-up was not well documented, resulting in 22 selected hips (21 patients) for final inclusion. These patients were matched with 22 patients (controls) who were selected from 474 consecutive aseptic revision procedures. Matching was performed---in decreasing order of importance---for previous surgery on trochanter, number of revisions of the cup, number of revisions of the stem, type of implant, use of transfemoral osteotomy, Charnley score, duration of follow-up, age, and sex. In group 2, 5 hips were excluded all because of loss of 2 year follow-up resulting in 50 selected hips (48 patients) for final inclusion ([Figure 2](#F2){ref-type="fig"}), of which 34 hips had severely damaged soft tissues with a sinus and/or abcess formation.

![Flow of hips included in the study. Exclusion of 19 of 91 hips that did not fulfill the inclusion criteria.](ORT-0300-9734-082-027_g002){#F2}

12 of the 22 hips in group 1 (11 patients) and 39 of the 50 hips in group 2 (37 patients) had been referred. The referred cases had had more surgery before referral and qualified less often for a 1-stage exchange compared to the non-referred patients.

Staphylococci were the most commonly involved pathogens (40 hips) followed by *Streptococcus* spp. (11 hips) and gram-negative rods (8 hips). In 17 hips, the isolates were classified as difficult to treat, and included *Pseudomonas aeruginosa,* rifampin-resistant staphylococci, *Enterococcus* spp, MRSA, small-colony variants of *S. aureus,* and *Abiotrophia adiacens,* requiring a 2-stage exchange in these cases. In 10 hips the infection was polymicrobial, and in 3 hips no pathogen could be cultured.

Patients were followed up after 6 weeks, 3 months, 6 months, 1 year, 2 years, and every 5 years thereafter.

The mean clinical follow-up was 3.8 years (SD 2.2) for both group 1 and the control group, and 4.9 years (SD 3.6) for group 2. 19 of the 22 patients in group 1, all 22 in the control group, and 43 of the 50 hips in group 2 had an event-free survival for ≥ 2 years and qualified for functional outcome analysis.

Operative technique {#ss4}
-------------------

The index operation was defined as the reimplantation procedure done at our center. Bone defects on the latest preoperative radiographs were classified according to Paprosky ([@CIT0025], [@CIT0037]) ([Table 1](#T1){ref-type="table"}). Patients were operated in the supine position with a straight lateral approach. In 34 hips, this was combined with a transfemoral osteotomy ([@CIT0038]) ([Figure 3](#F3){ref-type="fig"}). In the infected cases, after removal of the components a thorough debridement was performed---taking care to preserve bone and soft tissue. In all groups, the choice of a particular implant was dictated by the classification of bone defects irrespective of the presence of infection. For reconstruction of the acetabulum, an uncemented cup (SL-Müller), a reinforcement ring (Müller), or a Burch-Schneider (BS) reinforcement ring (all Zimmer, Warsaw, IN) were used. Morselized autograft were added for small defects, and/or slices of allograft for larger defects. For reconstruction of the femur, an uncemented titanium stem (Wagner SL) or a cemented stem (Müller straight stem; CDH, Virtec) with gentamicin cement (Palacos) was used (all Zimmer, Warsaw, IN). In 2-stage procedures, reimplantation was performed after 3--5 weeks (damaged soft tissue) or after 6--8 weeks (difficult-to-treat bacteria). In group 2, a Burch-Schneider (BS) reinforcement ring was needed more often ([Table 2](#T2){ref-type="table"}).

###### 

Patient characteristics prior to the index operation

                                                  Matched [**^a^**](#T1-N1){ref-type="fn"}                                                                                  
  ------------------------------------- --------- ------------------------------------------ ---------------------------------- ------------------------------------------- -------------------------------------
  Total hip arthroplasties (patients)   22 (22)                                              22 (21)                                                                        50 (48)
  Age, median                           67        0.4 [**^b^**](#T1-N2){ref-type="fn"}       69                                 0.2 [**^b^**](#T1-N2){ref-type="fn"}        70
   range                                53--84                                               48--88                                                                         40--88
  Male                                  15        0.2 [**^c^**](#T1-N3){ref-type="fn"}       10                                 0.1 [**^c^**](#T1-N3){ref-type="fn"}        29
  Charnley classification                         0.9 [**^d^**](#T1-N4){ref-type="fn"}                                          0.15 [**^d^**](#T1-N4){ref-type="fn"}       
   A                                    12                                                   14                                                                             31
   B1                                   1                                                    1                                                                              0
   B2                                   9                                                    7                                                                              17
   C                                    0                                                    0                                                                              2
  Previous surgery performed            2         1.0 [**^c^**](#T1-N3){ref-type="fn"}       3                                  \< 0.001 [**^c^**](#T1-N3){ref-type="fn"}   39
   on trochanter                        2         1.0 [**^d^**](#T1-N4){ref-type="fn"}       2                                  0.4 [**^d^**](#T1-N4){ref-type="fn"}        17
   on cup, for any reason               1         0.3 [**^d^**](#T1-N4){ref-type="fn"}       0                                  0.002 [**^d^**](#T1-N4){ref-type="fn"}      23
   on stem, for any reason              2         1 [**^d^**](#T1-N4){ref-type="fn"}         2                                  0.01 [**^d^**](#T1-N4){ref-type="fn"}       25
   debridement(s)                       0         1 [**^d^**](#T1-N4){ref-type="fn"}         0                                  \< 0.001 [**^d^**](#T1-N4){ref-type="fn"}   70 [**^e^**](#T1-N5){ref-type="fn"}
  Girdlestone/spacer                    --                                                   --                                                                             4/2
  Proprosky classification cup                    0.5 [**^d^**](#T1-N4){ref-type="fn"}       [**^f^**](#T1-N6){ref-type="fn"}   0.004 [**^d^**](#T1-N4){ref-type="fn"}      [**^f^**](#T1-N6){ref-type="fn"}
   1                                    13                                                   15                                                                             17
   2A                                   3                                                    1                                                                              5
   2B                                   2                                                    2                                                                              5
   2C                                   2                                                    2                                                                              12
   3A                                   2                                                    1                                                                              6
   3B                                   0                                                    0                                                                              4
  Proprosky classification stem                   0.6 **[^d^](#T1-N4){ref-type="fn"}**       [**^f^**](#T1-N6){ref-type="fn"}   0.2 **[^d^](#T1-N4){ref-type="fn"}**        **[^f^](#T1-N6){ref-type="fn"}**
   I                                    0                                                    1                                                                              1
   II                                   17                                                   16                                                                             19
   IIIA                                 4                                                    3                                                                              20
   IIIB                                 1                                                    1                                                                              2
   IV                                   0                                                    0                                                                              7
  Deficient greater trochanter          1         1 **[^c^](#T1-N3){ref-type="fn"}**         1                                  0.05 **[^c^](#T1-N3){ref-type="fn"}**       12

**^a^** Control and group 1 were matched for all listed variables.

**^b^** Student t-test

**^c^** Chi-square test.

**^d^** Mann-Whitney U-test.

**^e^** 16 hips received ≥ 2 (range 2--10) debridements.

**^f^** One preoperative radiograph was not available.

![A 59-year-old woman with bilateral PI following *Staphylococcus aureus* sepsis, 2 years after bilateral 1-stage exchange. On the right side: reconstruction with a Müller reinforcement ring for a type-1 defect, and a long Wagner stem by transfemoral approach. On the left side: a reconstruction with a Burch-Schneider ring to bridge a type-2B defect. A cemented Virtec stem with transgluteal approach was implanted. At the 2-year follow-up, the HHS (bilateral) was 97, there was a slight limp, there were no radiographic signs of loosening, the transfemoral osteotomy was healed, and the infection was cured.](ORT-0300-9734-082-027_g003){#F3}

###### 

Surgical procedures and specifics at the index operation

                                                     Matched **[^a^](#T2-N1){ref-type="fn"}**                                               
  --------------------------------------------- ---- ------------------------------------------ ---- -------------------------------------- ----------------------------------
  No osteotomy                                  14   0.5 **[^b^](#T2-N2){ref-type="fn"}**       15   0.2 **[^b^](#T2-N2){ref-type="fn"}**   22
  Transfemoral osteotomy                        7    0.5                                        5    0.1                                    22
  Greater trochanter osteotomy                  1    1                                          1    0.5                                    1
  Approach via nonunion in greater trochanter   0    0.9                                        1    0.2                                    5
  Spacer                                        --   --                                         --   --                                     29
  Acetabular component                                                                                                                      **[^c^](#T2-N3){ref-type="fn"}**
   SL uncemented cup                            2    1 **[^b^](#T2-N2){ref-type="fn"}**         2    0.6 **[^b^](#T2-N2){ref-type="fn"}**   2
   Müller reinforcement ring                    16   1                                          16   0.08                                   24
   Burch-Schneider reinforcement ring           4    1                                          4    0.03                                   23
  Femoral component                                  1 **[^b^](#T2-N2){ref-type="fn"}**              0.8 **[^b^](#T2-N2){ref-type="fn"}**   **[^c^](#T2-N3){ref-type="fn"}**
   uncemented                                   11                                              11                                          26
   cemented                                     11                                              11                                          23
  Acetabular graft                                   0.2 **[^d^](#T2-N4){ref-type="fn"}**            0.9 **[^d^](#T2-N4){ref-type="fn"}**   **[^c^](#T2-N3){ref-type="fn"}**
   no graft                                     5                                               9                                           27
   autograft, morselized                        4                                               10                                          9
   allograft, blocks \> 2 cm or slices          2                                               3                                           10
   auto- and allograft                          1                                               0                                           3

**^a^** Control and group 1 were matched for all the variables listed.

**^b^** Chi-square test.

**^c^** In group 2, one patient died prior to reimplantation (see also complications, [Table 4](#T4){ref-type="table"}).

**^d^** Mann-Whitney U-test.

Infectiological, clinical, and radiographic evaluation {#ss5}
------------------------------------------------------

The infection was classified as "cured" when there were no signs of infection 2 years or more after implantation ([@CIT0011]). In case of death for an unrelated cause before the 2-year follow-up, infection was classified as "probably cured". Relapse was defined as an infection with the same pathogen, and reinfection was defined as an infection with a different microorganism. Functional outcome parameters were the Harris hip score (HHS), the presence of limping, and the use of a support, and they were only recorded in patients with an event-free follow-up at 2 years (no revision and no death). This time point was chosen because after 2 years, results decline due to patient-related factors ([@CIT0032]). Complications and reoperations were recorded for all the hips included.

For radiographic follow-up, AP radiographs of pelvis and femur faux--profiles views were scrutinized for signs of loosening according to [@CIT0010] for the acetabulum and according to [@CIT0014] for the femur. Migration and subsidence were measured ([@CIT0006]). In case of osteotomy or bone lesions, images were screened for signs of non-union. All radiographic variables were obtained from the latest available radiograph. Endpoints for both clinical and radiographical follow-up were re-revision or death.

Statistics {#ss6}
----------

Statistical comparisons for patient characteristics, surgical specifics, and functional, radiographic, and microbiological outcomes were conducted with chi-square and Student\'s t-test. For non-parametric data, the Mann-Whitney U test was used. For all 84 hips with an event-free follow-up, multiple univariate regression analysis (ANOVA) was performed to determine whether surgical parameters lead to lower functional outcome(s). Calculations were done with SPSS software version 15.0 and statistical significance was set at p \< 0.05.

Ethics {#ss7}
------

Informed consent was obtained from all patients. The study design was approved by the local ethics committee of the hospital district in which the study was conducted (01-05-2006; WN 420).

Results {#ss8}
=======

Infectiological outcome {#ss9}
-----------------------

In group 1, there was no relapse of infection but there was 1 case of reinfection with another pathogen. In group 2, there was 1 relapse of infection ([Table 3](#T3){ref-type="table"}).

###### 

Infectiological, functional, and radiographic outcome, and number of revisions

                                                                            Control     p-value                                 Group 1                               p-value                                Group 2
  ------------------------------------------------------------------------- ----------- --------------------------------------- ------------------------------------- -------------------------------------- -------------------------------------
  Infectiological outcome                                                                                                                                             0.5 **[^a^](#T3-N1){ref-type="fn"}**   
   total hip arthroplasties                                                 22                                                  22                                                                           50
   cured                                                                    --          --                                      19                                                                           46
   probably cured                                                           --          --                                      2                                                                            1
   relapse of infection with same pathogen                                  --          --                                      0                                                                            1
   reinfection with different pathogen                                      0           0.2 **[^b^](#T3-N2){ref-type="fn"}**    1                                                                            0
   unknown                                                                  --          --                                      0                                                                            2
  Functional outcome at 2-year follow-up                                                                                                                                                                     
   total hip arthroplasty **[^c^](#T3-N3){ref-type="fn"}**                  22                                                  19                                                                           43
   mean HHS (SD)                                                            85 (16)     0.9 **[^d^](#T3-N4){ref-type="fn"}**    84 (17)                               0.3 **[^d^](#T3-N4){ref-type="fn"}**   80 (18)
   mean HHS with/without spacer                                             --          --                                      --                                    --                                     80/78
   limping                                                                              0.5 **[^a^](#T3-N1){ref-type="fn"}**                                          0.5 **[^a^](#T3-N1){ref-type="fn"}**   
    none or slight                                                          19                                                  15                                                                           30
    moderate or severe                                                      3                                                   4                                                                            13
   walking                                                                              0.2 **[^a^](#T3-N1){ref-type="fn"}**                                          0.5 **[^a^](#T3-N1){ref-type="fn"}**   
    without support                                                         15                                                  9                                                                            18
    with one cane/crutch                                                    7                                                   8                                                                            13
    with two canes/crutches                                                 0                                                   2                                                                            11
    unable to walk/use of wheelchair                                        0                                                   0                                                                            1
  Radiographic outcome at last follow-up ^[**e**](#T3-N5){ref-type="fn"}^                                                                                                                                    
   total hip arthroplasties                                                 22                                                  20 **[^f^](#T3-N6){ref-type="fn"}**                                          47 **[^f^](#T3-N6){ref-type="fn"}**
   mean follow-up in years (SD)                                             4.8 (2.8)   0.05 **[^d^](#T3-N4){ref-type="fn"}**   3.3 (2.4)                             0.5 **[^d^](#T3-N4){ref-type="fn"}**   4.0 (3.7)
   definitive loosening of stem (revised)                                   1 (1)       0.5 **[^b^](#T3-N2){ref-type="fn"}**    2 (2)                                 0.9 **[^b^](#T3-N2){ref-type="fn"}**   4 (2)
   definitive loosening of cup (revised)                                    1 (0)       0.2 **[^b^](#T3-N2){ref-type="fn"}**    0                                     0.1 **[^b^](#T3-N2){ref-type="fn"}**   3 (1)
   stem subsidence \> 5 mm (revised)                                        0           --                                      0                                     0.6 **[^b^](#T3-N2){ref-type="fn"}**   2 (0)

**^a^** Mann-Whitney U-test.

**^b^** Chi-square test.

**^c^** Only hips with an event-free survival for ≥ 2 years were included in functional outcome analyses.

**^d^** Student t-test.

**^e^** Statistical analysis was performed with endpoints definitive component loosening and stem subsidence \> 5 mm.

**^f^** For 2 hips, in group 1 and group 2, radiographs were not available since the patients died prior to the follow-up examinations. Also, postoperative radiographs were not available for another hip in group 2.

Functional and radiographic outcome, revisions, and complications {#ss10}
-----------------------------------------------------------------

### Control vs. group 1 {#ss11}

We did not find any statistically significant differences in the functional parameters HHS, limping, and use of support---or in radiographic parameters---between the 2 groups. Definitive loosening of the stem with subsequent revision occurred in 2 hips in group 1 and in 1 hip in the control group ([Table 3](#T3){ref-type="table"}). 1 cup in the control group showed signs of definitive loosening but the hip score was 100 and revision was not performed. All osteotomies and the pre-existing nonunion of the greater trochanter healed successfully. 1 iatrogenic fracture of the greater trochanter that occurred in group 1 developed a nonunion. The total number of postoperative complications and re-interventions was similar in both groups ([Table 4](#T4){ref-type="table"}).

###### 

Number of complications associated with the index operation

                                         Control   p-value                                Group 1   p-value                                  Group 2
  -------------------------------------- --------- -------------------------------------- --------- ---------------------------------------- ------------------------------------
  Total hip arthroplasties               22 (22)                                          22 (21)                                            50 (48)
  Surgical complications                                                                                                                     
   fracture, greater trochanter          3                                                1                                                  1
   fracture/fissure, proximal femur      1                                                3                                                  2
  Post-surgical complications                                                                                                                
   requiring reoperation                                                                                                                     
    hematoma                             2                                                1                                                  17
    wound infection                      0                                                0                                                  1
    pin tract infection                  --                                               --                                                 1
   requiring closed reduction                                                                                                                
    dislocation of spacer                --                                               --                                                 1
    dislocation of hip                   0                                                0                                                  6
   total reinterventions                 2         0.5 **[^a^](#T4-N1){ref-type="fn"}**   1         0.004 **[^a^](#T4-N1){ref-type="fn"}**   26
  Total (post-) surgical complications   6         0.9 **[^a^](#T4-N1){ref-type="fn"}**   5         0.03 **[^a^](#T4-N1){ref-type="fn"}**    29
  Non-surgical complications                                                                                                                 
   during hospitalization                                                                                                                    
    thrombosis/emboli                    0                                                0                                                  2
    miscellaneous                        1                                                3                                                  4
    early death                          0                                                0                                                  2 **[^b^](#T4-N2){ref-type="fn"}**

**^a^** Mann-Whitney U-test.

**^b^** Death due to heart failure and pneumonia, one month after the index operation.

### Group 1 vs. group 2 {#ss12}

Comparing both groups, all functional outcomes were lower in group 2 but the differences were not statistically significant ([Table 3](#T3){ref-type="table"}). Also, radiographic results were not significally different between groups 1 and 2. In group 2, 4 stems showed signs of definitive loosening and 2 of those were revised; the other 2 stems showed subsidence of 4 mm and 28 mm, but they remained stable and patient co-morbidity did not allow intervention. Also, 3 cups were definitively loose: 1 of them (a Müller reinforcement ring) was revised and the other 2 (BS-rings) did not cause symptoms ([Table 3](#T3){ref-type="table"}). 1 of the transfemoral osteotomies and the only trochanteric osteotomy developed a nonunion. 2 of the 5 pre-existing nonunions of the greater trochanter persisted. All intraoperative fractures of the proximal femur healed uneventfully. Group 2 had a higher incidence of (post-) surgical complications, mainly due to more postoperative hematomas and dislocations, and had more re-interventions ([Table 4](#T4){ref-type="table"}).

Surgery-related parameters and functional outcome {#ss13}
-------------------------------------------------

The use of a transfemoral osteotomy was not associated with lower functional outcome (p = 0.1 for HHS; p = 0.2 for limping; p = 0.9 for use of support). A deficient greater trochanter (p = 0.01 for limping; p = 0.05 for use of support), the use of a BS-ring (p = 0.03 for limping), a trochanteric osteotomy (p = 0.05 for use of support), and a history of multiple cup revisions (p = 0.06 for use of support) were associated with lower functional outcome.

Discussion {#ss14}
==========

A commonly proposed treatment strategy for PI is a 2-stage procedure with up to a 6-month interval between surgeries ([@CIT0023], [@CIT0001], [@CIT0007], [@CIT0022], [@CIT0024], [@CIT0009], [@CIT0021], [@CIT0039]). However, the use of a 1-stage exchange provides several advantages such as lower perioperative morbidity, a shorter hospital stay, lower costs, and earlier rehabilitation ([@CIT0005], [@CIT0041], [@CIT0029], [@CIT0030], 1996, [@CIT0036], [@CIT0003]). Yet, the results of some reports indicate the possibility of a higher relapse rate ([@CIT0029], [@CIT0030]). This implies that only selected patients may benefit from a 1-stage procedure. With this line of reasoning, we have established an algorithm that selects patients for either a 1-stage exchange or a 2-stage exchange according to well-defined criteria ([@CIT0043]). In agreement with our previous studies ([@CIT0011], [@CIT0034]), we found a very low relapse rate of infection in the patients in the present study. In the study, we focused on functional outcome.

This study had several limitations. First, the number of patients was small. On the other hand, our analysis included only hips that were treated according to a strict protocol with a multidisciplinary approach, and there was almost no relapse. Inclusion of the simultaneous analysis of functional, radiographic, and infectiological parameters is crucial when judging the outcome of a treatment algorithm for PI. Also, we applied strict methodological criteria to functional outcome evaluation by only including hips that had an event-free follow-up of at least 2 years. Given these study constraints, it is conceivable that the sizes of the groups were relatively small. We cannot exclude the possibility that the statistically insignificant differences we found between infectious and non-infectious hips might have become significant in a larger series. However, in our view it is not feasible to perform a study with the high numbers of hips required from a statistical point of view that would also include a standardized treatment and a multidisciplinary follow-up as performed in our study. We believe that our analysis was conducted on a solid study population and reflects clinical reality. Secondly, the preoperative functional scores were not available for the hips included in the study. This partially limits the interpretation of the 2-year HHS. However, many patients had had previous surgery and complaints due to infection; thus, such preoperative scores would not allow any reliable comparison with the postoperative state. Thirdly, we used several different implants. As in any revision surgery, the variability in quality of bone is often substantial, requiring an individual choice of implant; our algorithm was not bound to any preferred reconstruction technique. Finally, functional outcome was based on only 3 variables (i.e. HHS, limping, and walking support). We focused on simple variables, however, to allow comparison between groups, and between our results and those reported in the literature.

HHS was almost identical in the 1-stage group and in the control group (mean HHS of 84 and 85). Moreover, the values were higher when compared to a report of 31 one-stage procedures for infection, in which the mean HHS was 75 after 3.5 years ([@CIT0035]). In a recent meta-analysis of 24 studies analyzing mainly aseptic revisions, the mean HHS was 82 after a mean follow-up of 4 years ([@CIT0033]). The high functional scores after 1-stage exchange can be partly explained by the design of the algorithm, because it selects less complex cases for such procedures.

This means that the algorithm selects more complex cases for a 2-stage exchange. These cases had moderately or severely damaged soft tissue (i.e. sinus tract, multiple previous surgeries), or involved a difficult-to-treat microorganism. Since a 2-stage exchange is only performed in cases of infection, there was no matched control group available. Even so, the functional scores of the 2-stage group were good (mean HHS of 80), although they were lower than those of the 1-stage group (mean HHS of 84). A difference of 4 points may be clinically important ([@CIT0016]) and such a discrepancy is not surprising considering the preoperative conditions---including multiple surgeries, more serious infections, limited bone stock, and deficiency of the greater trochanter. Consequently, the surgical procedure becomes more complex. The Harris hip scores in our study (80--85) are similar to those in the literature, where the scores reported have ranged from 72 to 91 ([@CIT0021], [@CIT0012]).

A transfemoral osteotomy, an important feature of our surgical technique, was not associated with poor functional outcome. With this technique ([@CIT0038]), safe removal of the components and a thorough debridement can be achieved. None of the osteotomies were associated with a periprosthetic fracture; the only relapse of infection occurred in a case of osteotomy but appeared not to be related to this technique, and another developed a nonunion. An important aspect of our treatment strategy is that we strive to preserve bone and soft tissue as much as possible in order to optimize the functional result. This contrasts with other surgical regimens where infected tissue is radically debrided or even resected ([@CIT0008], [@CIT0040]). In our study, infections were eliminated in almost all cases without the need for aggressive removal of bone and soft tissue.

We found that a trochanter deficiency and the use of a BS-ring were associated with an increased risk of limping. Whereas the occurrence of limping may be explained by the presence of a deficient trochanter with impairment of the abductor apparatus, this appears to be less evident with the use of a BS-ring. It has been proposed that the exposure of the ileum may damage the anterior part of the gluteus medius muscle or the superior gluteal nerve ([@CIT0028], [@CIT0026], [@CIT0017]). However, this finding may also be due to a confounding factor, considering that a BS-ring was implanted in 6 of 14 patients with a trochanter deficiency. The uncemented Wagner SL stem was associated with a good functional outcome and in contrast to previous reports ([@CIT0015], [@CIT0019], [@CIT0002]), stem subsidence was uncommon. The incidence of loosening of acetabular and femoral components was low and similar to that for identical implants used in aseptic revision surgery with equal length of follow-up ([@CIT0013], [@CIT0020], [@CIT0027], [@CIT0018]).

Considering the criteria in our algorithm (including the causative pathogen), we found that some of the referred cases should have been treated with a 1-stage exchange or a 2-stage exchange a priori, instead of having inadequate trials of debridement with implant retention or 1-stage exchange, respectively. Initial treatment failure with prosthetic infections increases the probability of a requirement for a more complex procedure (2-stage exchange) with a greater burden for the patients, and might therefore end in an inferior functional outcome.

Our findings support the idea of using well-defined criteria in order to select an optimal surgical strategy for patients with prosthetic infections. In our experience, the algorithm used here provides such criteria, and is therefore helpful in the surgical decision making. In this way, relapse of infection and impairment of the functional outcome can be avoided.
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